Elanco shareholders approve board declassification, majority voting, and special meeting rights

Elanco Animal Health Inc

Board declassified, majority vote standard adopted for uncontested director elections.
Shareholders granted right to amend bylaws and request special meetings under certain conditions.
Kathy Turner reappointed to 2025 class, Lawrence Kurzius to 2026 class to rebalance board terms.
All four director nominees elected with votes ranging from 337M to 373M for.
Auditor Ernst & Young ratified (454M for, 1.6M against); say-on-pay approved (409M for, 31M against).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.